Anti-myelin oligodendrocyte glycoprotein antibody-associated encephalitis with cortical hyperintensity and pathologically confirmed extensive demyelination

[1]  K. Fujihara,et al.  Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. , 2020, Brain : a journal of neurology.

[2]  C. Lucchinetti,et al.  The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody , 2020, Acta Neuropathologica.

[3]  A. Mirian,et al.  Unilateral cortical FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome , 2019, Journal of Neurology.

[4]  A. Saiz,et al.  Anti-MOG encephalitis mimicking small vessel CNS vasculitis , 2019, Neurology: Neuroimmunology & Neuroinflammation.

[5]  H. Li,et al.  Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single‐center cohort study in Shanghai, China , 2018, European journal of neurology.

[6]  T. Misu,et al.  The pathological features of MOG antibody-positive cerebral cortical encephalitis as a new spectrum associated with MOG antibodies: A case report , 2018, Journal of the Neurological Sciences.

[7]  K. Fujihara,et al.  Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[8]  K. Fujihara,et al.  MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy , 2017, Neurology: Neuroimmunology & Neuroinflammation.

[9]  A. Venkatesan,et al.  A clinical approach to diagnosis of autoimmune encephalitis , 2016, The Lancet Neurology.

[10]  K. Fujihara,et al.  Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders , 2014, Neurology.